Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
Alpheus Medical, Inc.
Alpheus Medical, Inc.
Black Diamond Therapeutics, Inc.
Centre Oscar Lambret
RasCal Therapeutics, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Beijing Biotech
University of California, San Francisco
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Filamon LTD
Memorial Sloan Kettering Cancer Center
Sunnybrook Health Sciences Centre
University of California, San Francisco
NovoCure Ltd.
Dana-Farber Cancer Institute
Nationwide Children's Hospital
Telix Pharmaceuticals (Innovations) Pty Limited
BioNTech SE
Abramson Cancer Center at Penn Medicine
University Hospital Heidelberg
Sunnybrook Health Sciences Centre
St. Joseph's Hospital and Medical Center, Phoenix
M.D. Anderson Cancer Center
Nuvation Bio Inc.
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center
Nationwide Children's Hospital
Nationwide Children's Hospital
GT Medical Technologies, Inc.
University of Aarhus
Boston Scientific Corporation
Neonc Technologies, Inc.
Eastern Cooperative Oncology Group
Debiopharm International SA
M.D. Anderson Cancer Center
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center
Diakonos Oncology Corporation
Mayo Clinic
Assistance Publique - Hôpitaux de Paris
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
EMD Serono
Essen Biotech
Essen Biotech
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC